FDA authorizes emergency use of new SARS-CoV-2 diagnostic tests
The Food and Drug Administration authorized the University of California San Francisco’s Clinical Labs at China Basin to use a new molecular-based diagnostic test for SARS-CoV-2.
The agency also authorized laboratories certified to perform high complexity tests under the Clinical Laboratory Improvement Amendments to use a new molecular-based diagnostic test developed by BioSewoom Inc.
Related News Articles
Headline
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…